Senior insider sale
PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$76.1K
22K shares
What this filing means
MOYES JAY M plans to sell 22K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $76.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/13/2023ACC: 0001842612-23-000009
22K
Shares to sell
$76.1K
Approx. market value
27K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation for Services Rendered
6/13/2023
27KTotal acquired27K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/13/2023 | Restricted Stock Unit Vesting Compensation for Services Rendered | 27K | — |
| Total | 27K | ||
Planned & Completed Dispositions1
NASDAQGSPlanned
Units to sell
22K
Market value
$76.1K
6/13/2023
Total
Units
22K
Value
$76.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/13/2023 | 22K | $76.1K | NASDAQGS | Planned |
| Total | 22K | $76.1K | ||